We are live on ! Find out more
Two Sigma Advisers

Two Sigma Advisers Portfolio holdings

AUM $51.4B
1-Year Est. Return 31.07%
This Fund
S&P 500
This Quarter Est. Return
+9.38%
1 Year Est. Return
+31.07%
3 Year Est. Return
+128.94%
5 Year Est. Return
+161.75%
10 Year Est. Return
+607.04%
AUM
$43.1B
AUM Growth
+$2.24B
Cap. Flow
-$849M
Cap. Flow %
-1.97%
Top 10 Hldgs %
11.85%
Holding
2,563
New
364
Increased
1,030
Reduced
917
Closed
227

Top Buys

Rank Stock Value
1
MRK icon
Merck
MRK
+$245M
2
META icon
Meta Platforms (Facebook)
META
+$204M
3
EXC icon
Exelon
EXC
+$196M
4
SHW icon
Sherwin-Williams
SHW
+$182M
5
PFE icon
Pfizer
PFE
+$174M

Sector Composition

Rank Sector Weight
1 Technology 16.65%
2 Healthcare 16.47%
3 Consumer Discretionary 15.27%
4 Industrials 11.92%
5 Financials 8.21%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CFB
2076
DELISTED
CrossFirst Bankshares, Inc. Common Stock
CFB
$290K ﹤0.01%
20,100
TWOU
2077
DELISTED
2U Inc
TWOU
$290K ﹤0.01%
+403
New +$251K
PDLI
2078
DELISTED
PDL BioPharma, Inc.
PDLI
$290K ﹤0.01%
89,269
-379,221
-81% -$1.1M
BP icon
2079
BP
BP
$113B
$288K ﹤0.01%
7,626
-195,700
-96% -$7.43M
HTH icon
2080
Hilltop Holdings
HTH
$2.29B
$285K ﹤0.01%
11,413
-71,500
-86% -$1.75M
KINS icon
2081
Kingstone Companies
KINS
$288M
$284K ﹤0.01%
36,600
-5,800
-14% -$46.1K
D icon
2082
Dominion Energy
D
$62.5B
$282K ﹤0.01%
+3,399
New +$278K
APTX
2083
DELISTED
Aptinyx Inc. Common Stock
APTX
$282K ﹤0.01%
82,600
-10,000
-11% -$34.4K
EIDX
2084
DELISTED
Eidos Therapeutics, Inc. Common Stock
EIDX
$281K ﹤0.01%
+4,900
New +$243K
DXPE icon
2085
DXP Enterprises
DXPE
$2.62B
$280K ﹤0.01%
7,044
+400
+6% +$14.9K
SLAB icon
2086
Silicon Laboratories
SLAB
$7.15B
$279K ﹤0.01%
+2,407
New +$264K
CBIO
2087
Crescent Biopharma
CBIO
$602M
$278K ﹤0.01%
+526
New +$285K
ZVO
2088
DELISTED
Zovio Inc. Common Stock
ZVO
$277K ﹤0.01%
134,658
-15,000
-10% -$30K
BBT
2089
Beacon Financial Corp
BBT
$2.53B
$276K ﹤0.01%
+8,400
New +$263K
SBH icon
2090
Sally Beauty Holdings
SBH
$1.4B
$276K ﹤0.01%
+15,100
New +$262K
AXDX
2091
DELISTED
Accelerate Diagnostics
AXDX
$275K ﹤0.01%
+1,630
New +$269K
IDT icon
2092
IDT Corp
IDT
$1.6B
$274K ﹤0.01%
37,941
+100
+0.3% +$720
TBHC
2093
DELISTED
The Brand House Collective
TBHC
$274K ﹤0.01%
221,089
-800
-0.4% -$1.07K
ENZ
2094
DELISTED
Enzo Biochem, Inc.
ENZ
$274K ﹤0.01%
104,057
-18,200
-15% -$54.4K
EQH icon
2095
Equitable Holdings
EQH
$13.1B
$273K ﹤0.01%
+11,000
New +$255K
PERI icon
2096
Perion Network
PERI
$367M
$272K ﹤0.01%
+43,700
New +$230K
AXGN icon
2097
Axogen
AXGN
$2.1B
$270K ﹤0.01%
15,100
-81,100
-84% -$1.2M
MCRB icon
2098
Seres Therapeutics
MCRB
$48M
$268K ﹤0.01%
3,880
+730
+23% +$54.1K
AXAS
2099
DELISTED
Abraxas Petroleum Corp
AXAS
$268K ﹤0.01%
38,202
-450
-1% -$2.9K
GHG
2100
GreenTree Hospitality
GHG
$113M
$267K ﹤0.01%
24,300
-4,100
-14% -$44.5K

Similar funds

Two Sigma Advisers's Q4 2019 Portfolio in Review

As of Q4 2019, Two Sigma Advisers held 2,563 positions worth $43.1B, up 5.5% from $40.9B the previous quarter. Its ten largest holdings account for 12% of the portfolio.

Two Sigma Advisers's Q4 2019 filing shows 364 new, 1,030 increased, 917 reduced and 227 closed positions. Its largest new stake was Netflix: 5,465,000 shares worth $177M. The largest sale was Microsoft, an estimated $400M.

By sector, the portfolio is most concentrated in Technology at 17% of assets, down from 20% a quarter earlier, followed by Healthcare and Consumer Discretionary.

  • Two Sigma Advisers's largest Q4 2019 buy was Netflix: 5,465,000 shares worth $177M.
  • Two Sigma Advisers added most to Merck in Q4 2019, an estimated $245M increase.
  • Two Sigma Advisers's biggest Q4 2019 reduction was Microsoft, cutting an estimated $400M.
  • Two Sigma Advisers fully exited Fidelity National Information Services in Q4 2019, selling an estimated $280M.
  • Two Sigma Advisers's ten largest holdings make up 12% of its $43.1B portfolio in Q4 2019.
  • Two Sigma Advisers opened 364 new positions and closed 227 in Q4 2019.
  • Two Sigma Advisers's portfolio value rose 5.5% quarter-over-quarter to $43.1B.

Based on Two Sigma Advisers's 13F filing for Q4 2019, filed 14 Feb 2020.